midazolam has been researched along with Recrudescence in 33 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This trial will provide efficacy, safety and health economic data on serial ketamine infusions and thus help inform clinical practice on the potential role of this treatment in the management of depression." | 9.69 | Study protocol for Ketamine as an adjunctive therapy for major depression (2): a randomised controlled trial (KARMA-Dep [2]). ( Igoe, A; Jelovac, A; Loughran, O; McCaffrey, C; McDonagh, K; McDonogh, S; McLoughlin, DM; Mohamed, E; O'Neill, C; Shackleton, E; Shanahan, E; Terao, M; Whooley, E, 2023) |
| "After the administration of midazolam, the 5 patients with left hemisphere stroke demonstrated reemergence or worsening of their initial right hemiparesis and aphasia but showed no left neglect." | 9.10 | Reemergence of stroke deficits with midazolam challenge. ( Berman, MF; Bustillo, MA; Fitzsimmons, BF; Lazar, RM; Marshall, RS; Mohr, JP; Robinson, JV; Shah, J; Young, WL, 2002) |
| "IM midazolam is an effective anticonvulsant for children with motor seizures." | 9.08 | A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. ( Altieri, MA; Chamberlain, JM; Futterman, C; Ochsenschlager, DW; Waisman, Y; Young, GM, 1997) |
| "BACKGROUND Recurrent seizure in patients with magnesium sulfate-treated eclampsia is very rare and requires meticulous management due to poor prognosis." | 7.88 | Recurrent Seizures in 2 Patients with Magnesium Sulfate-Treated Eclampsia at a Secondary Hospital. ( Achmadi, A; Aldika Akbar, MI; Harsono, AAH; Joewono, HT, 2018) |
| " The investigators studied a patient with a nortriptyline HCI level of 1,205 ng/mL who had four generalized grand mal seizures, each lasting between 60 and 90 seconds that were immediately followed by hypotension requiring norepinephrine support." | 7.69 | Recurrent hypotension immediately after seizures in nortriptyline overdose. ( Bell, A; Gaynor, B; Lipper, B, 1994) |
| "Midazolam is a valuable treatment option for refractory status epilepticus, especially in pediatric patients." | 6.40 | Use of midazolam for refractory status epilepticus in pediatric patients. ( Pellock, JM, 1998) |
| " This trial will provide efficacy, safety and health economic data on serial ketamine infusions and thus help inform clinical practice on the potential role of this treatment in the management of depression." | 5.69 | Study protocol for Ketamine as an adjunctive therapy for major depression (2): a randomised controlled trial (KARMA-Dep [2]). ( Igoe, A; Jelovac, A; Loughran, O; McCaffrey, C; McDonagh, K; McDonogh, S; McLoughlin, DM; Mohamed, E; O'Neill, C; Shackleton, E; Shanahan, E; Terao, M; Whooley, E, 2023) |
| "The control index seizure was the preceding, alternatively the next successive seizure without application of in-MDZ." | 5.42 | Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic-clonic seizures. ( Bauer, S; Belke, M; Fründ, D; Kay, L; Knake, S; Reif, PS; Rosenow, F; Strzelczyk, A, 2015) |
| "Recurrence or exacerbation of phantom limb pain induced by regional anesthesia including spinal anesthesia, epidural anesthesia, and peripheral nerve block has been described in a few reports." | 5.35 | Midazolam as an effective drug for severe phantom limb pain in a patient after undergoing spinal anesthesia for two consecutive surgeries in the contralateral lower limb. ( Liu, K; Su, CJ; Wang, YM, 2009) |
| "This double-blind, randomized, noninferiority trial compared the efficacy of intramuscular midazolam with that of intravenous lorazepam for children and adults in status epilepticus treated by paramedics." | 5.16 | Intramuscular versus intravenous therapy for prehospital status epilepticus. ( Barsan, W; Conwit, R; Durkalski, V; Lowenstein, D; Palesch, Y; Pancioli, A; Silbergleit, R, 2012) |
| "After the administration of midazolam, the 5 patients with left hemisphere stroke demonstrated reemergence or worsening of their initial right hemiparesis and aphasia but showed no left neglect." | 5.10 | Reemergence of stroke deficits with midazolam challenge. ( Berman, MF; Bustillo, MA; Fitzsimmons, BF; Lazar, RM; Marshall, RS; Mohr, JP; Robinson, JV; Shah, J; Young, WL, 2002) |
| "IM midazolam is an effective anticonvulsant for children with motor seizures." | 5.08 | A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. ( Altieri, MA; Chamberlain, JM; Futterman, C; Ochsenschlager, DW; Waisman, Y; Young, GM, 1997) |
| "BACKGROUND Recurrent seizure in patients with magnesium sulfate-treated eclampsia is very rare and requires meticulous management due to poor prognosis." | 3.88 | Recurrent Seizures in 2 Patients with Magnesium Sulfate-Treated Eclampsia at a Secondary Hospital. ( Achmadi, A; Aldika Akbar, MI; Harsono, AAH; Joewono, HT, 2018) |
| " A continuous low dose IV midazolam infusion was added to his treatment regimen (as is instituted for recalcitrant postoperative nausea and vomiting) with benefit, but not total symptom resolution." | 3.73 | Use of intravenous midazolam and clonidine in cyclical vomiting syndrome: a case report. ( Cameron, DJ; Palmer, GM, 2005) |
| " The investigators studied a patient with a nortriptyline HCI level of 1,205 ng/mL who had four generalized grand mal seizures, each lasting between 60 and 90 seconds that were immediately followed by hypotension requiring norepinephrine support." | 3.69 | Recurrent hypotension immediately after seizures in nortriptyline overdose. ( Bell, A; Gaynor, B; Lipper, B, 1994) |
| "Ketamine has a robust antidepressant effect, but there are no reported studies of ketamine for depression relapse prevention." | 2.90 | Ketamine Versus Midazolam for Depression Relapse Prevention Following Successful Electroconvulsive Therapy: A Randomized Controlled Pilot Trial. ( Daly, L; Finnegan, M; Galligan, T; Harkin, A; McLoughlin, DM; Ryan, K; Shanahan, E, 2019) |
| "Neither midazolam-induced laryngospasm nor its reversal with flumazenil have previously been reported." | 2.40 | Reversal of midazolam-induced laryngospasm with flumazenil. ( Davis, DP; Hamilton, RS; Webster, TH, 1998) |
| "Midazolam is a valuable treatment option for refractory status epilepticus, especially in pediatric patients." | 2.40 | Use of midazolam for refractory status epilepticus in pediatric patients. ( Pellock, JM, 1998) |
| "Acute treatment of breakthrough seizures and clusters of seizures at home with rectal BZDs (usually DZP, 0." | 2.39 | Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment. ( Mitchell, WG, 1996) |
| "Immediate recurrence of atrial fibrillation occurred in 89 patients (8." | 1.51 | Safety and efficacy of a cardiologist-only approach to deep sedation for electrical cardioversion. ( Bolzan, B; Borio, G; Morani, G; Ribichini, FL, 2019) |
| "At discharge, all survivors were seizure free." | 1.51 | Treatment options in pediatric super-refractory status epilepticus. ( Arayakarnkul, P; Chomtho, K, 2019) |
| "Because of recurrence and aggravation of respiratory distress, she now presented at the Department of Thoracic Surgery, and was scheduled for surgery." | 1.48 | Anesthetic Management in Tracheal Dilatation for Severe Tracheal Stenosis. ( Ito, K; Iwazaki, M; Kan, T; Kohno, M; Saito, K; Suzuki, T; Tetsu, S; Yamazaki, K, 2018) |
| "The control index seizure was the preceding, alternatively the next successive seizure without application of in-MDZ." | 1.42 | Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic-clonic seizures. ( Bauer, S; Belke, M; Fründ, D; Kay, L; Knake, S; Reif, PS; Rosenow, F; Strzelczyk, A, 2015) |
| "Recurrence of Crohn's disease (CD) most commonly occurs in the neoterminal ileum near the stoma after fecal diverting ileostomy." | 1.37 | Ileoscopy via stoma after diverting ileostomy: a safe and effective tool to evaluate for Crohn's recurrence of neoterminal ileum. ( Alkhouri, N; Lopez, R; Mahajan, L; Shen, B; Vadlamudi, N, 2011) |
| "Recurrence or exacerbation of phantom limb pain induced by regional anesthesia including spinal anesthesia, epidural anesthesia, and peripheral nerve block has been described in a few reports." | 1.35 | Midazolam as an effective drug for severe phantom limb pain in a patient after undergoing spinal anesthesia for two consecutive surgeries in the contralateral lower limb. ( Liu, K; Su, CJ; Wang, YM, 2009) |
| "Chronic anal fissure is the main cause of anal pain and is very common." | 1.31 | Open lateral sphincterotomy is still the best treatment for chronic anal fissure. ( Argov, S; Levandovsky, O, 2000) |
| "Open day-case repair of recurrent inguinal hernias can safely be conducted under unmonitored local anaesthesia with minimal morbidity." | 1.31 | Feasibility of local infiltration anaesthesia for recurrent groin hernia repair. ( Bech, K; Callesen, T; Kehlet, H, 2001) |
| "In the CS group, PTAs had a low recurrence rate of 1 (3." | 1.30 | Conscious sedation: a new approach for peritonsillar abscess drainage in the pediatric population. ( Lusk, RP; Muntz, HR; Park, J; Piccirillo, JF; Suskind, DL, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (30.30) | 18.2507 |
| 2000's | 14 (42.42) | 29.6817 |
| 2010's | 8 (24.24) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Jelovac, A | 1 |
| McCaffrey, C | 1 |
| Terao, M | 1 |
| Shanahan, E | 2 |
| Mohamed, E | 1 |
| Whooley, E | 1 |
| McDonagh, K | 1 |
| McDonogh, S | 1 |
| Igoe, A | 1 |
| Loughran, O | 1 |
| Shackleton, E | 1 |
| O'Neill, C | 1 |
| McLoughlin, DM | 2 |
| Ito, K | 1 |
| Yamazaki, K | 1 |
| Kan, T | 1 |
| Tetsu, S | 1 |
| Saito, K | 1 |
| Kohno, M | 1 |
| Iwazaki, M | 1 |
| Suzuki, T | 1 |
| Harsono, AAH | 1 |
| Achmadi, A | 1 |
| Aldika Akbar, MI | 1 |
| Joewono, HT | 1 |
| Morani, G | 1 |
| Borio, G | 1 |
| Bolzan, B | 1 |
| Ribichini, FL | 1 |
| Arayakarnkul, P | 1 |
| Chomtho, K | 1 |
| Finnegan, M | 1 |
| Galligan, T | 1 |
| Ryan, K | 1 |
| Harkin, A | 1 |
| Daly, L | 1 |
| Kay, L | 1 |
| Reif, PS | 1 |
| Belke, M | 1 |
| Bauer, S | 1 |
| Fründ, D | 1 |
| Knake, S | 1 |
| Rosenow, F | 1 |
| Strzelczyk, A | 1 |
| Prüss, H | 1 |
| Holtkamp, M | 1 |
| Su, CJ | 1 |
| Liu, K | 1 |
| Wang, YM | 1 |
| Wheless, JW | 1 |
| Vadlamudi, N | 1 |
| Alkhouri, N | 1 |
| Mahajan, L | 1 |
| Lopez, R | 1 |
| Shen, B | 1 |
| Silbergleit, R | 1 |
| Durkalski, V | 1 |
| Lowenstein, D | 1 |
| Conwit, R | 1 |
| Pancioli, A | 1 |
| Palesch, Y | 1 |
| Barsan, W | 1 |
| Riedl, B | 1 |
| Mitchell, AR | 1 |
| Spurrell, PA | 1 |
| Sulke, N | 1 |
| Maegaki, Y | 1 |
| Ogura, K | 1 |
| Ohno, K | 1 |
| Palmer, GM | 1 |
| Cameron, DJ | 1 |
| Knott, JC | 1 |
| Taylor, DM | 1 |
| Castle, DJ | 1 |
| Honda, A | 1 |
| Arai, T | 1 |
| Akiyama, M | 1 |
| Masuda, E | 1 |
| Kobayashi, M | 1 |
| Hoka, S | 1 |
| Lipper, B | 1 |
| Bell, A | 1 |
| Gaynor, B | 1 |
| Mitchell, WG | 1 |
| Robb, ND | 1 |
| Ramani, S | 1 |
| Karnad, AB | 1 |
| Chamberlain, JM | 1 |
| Altieri, MA | 1 |
| Futterman, C | 1 |
| Young, GM | 1 |
| Ochsenschlager, DW | 1 |
| Waisman, Y | 1 |
| Perera, I | 1 |
| Lim, L | 1 |
| Davis, DP | 1 |
| Hamilton, RS | 1 |
| Webster, TH | 1 |
| Pellock, JM | 1 |
| Suskind, DL | 1 |
| Park, J | 1 |
| Piccirillo, JF | 1 |
| Lusk, RP | 1 |
| Muntz, HR | 1 |
| Argov, S | 1 |
| Levandovsky, O | 1 |
| Claassen, J | 1 |
| Hirsch, LJ | 1 |
| Emerson, RG | 1 |
| Bates, JE | 1 |
| Thompson, TB | 1 |
| Mayer, SA | 1 |
| Lazar, RM | 1 |
| Fitzsimmons, BF | 1 |
| Marshall, RS | 1 |
| Berman, MF | 1 |
| Bustillo, MA | 1 |
| Young, WL | 1 |
| Mohr, JP | 1 |
| Shah, J | 1 |
| Robinson, JV | 1 |
| Callesen, T | 1 |
| Bech, K | 1 |
| Kehlet, H | 1 |
| Di Piero, V | 1 |
| Di Legge, S | 1 |
| Altieri, M | 1 |
| Lenzi, GL | 1 |
| Rowe, RW | 1 |
| Garbin, GS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study to Assess the Efficacy of Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy[NCT05019885] | Phase 2 | 6 participants (Anticipated) | Interventional | 2022-08-26 | Recruiting | ||
| A Double-blind Randomized Clinical Trial of the Efficacy of IM Midazolam Versus IV Lorazepam in the Pre-hospital Treatment of Status Epilepticus by Paramedics[NCT00809146] | Phase 3 | 1,023 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| Oro-dispersible Olanzapine (Wafer) Versus Conventional Oral Haloperidol or Diazepam Tablets for the Management of Acute Agitation in the Accident and Emergency Department - a Multicentre Randomised Clinical Trial[NCT03246620] | Phase 4 | 12 participants (Actual) | Interventional | 2017-09-01 | Terminated (stopped due to The study was terminated prematurely due to difficulties in patient recruitment and associated potential for selection bias.) | ||
| Intramuscular Olanzapine Versus Haloperidol or Midazolam for the Management of Acute Agitation in the Emergency Department - a Multicentre Randomised Clinical Trial[NCT02380118] | Phase 4 | 167 participants (Actual) | Interventional | 2014-12-31 | Terminated (stopped due to Primary endpoint reached based on data projection from interim analysis.) | ||
| Intranasal Midazolam Versus Rectal Diazepam for the Home Treatment of Seizure Activity in Pediatric Patients With Epilepsy[NCT00326612] | Phase 2 | 358 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Continuous acute care inpatient hospital days from day of admission until discharge (NCT00809146)
Timeframe: participants were followed for the duration of hospital stay, an average of 6 days
| Intervention | days (Mean) |
|---|---|
| IM Midazolam | 6.7 |
| IV Lorazepam | 5.5 |
Continuous days of initial ICU stay from time of admission (NCT00809146)
Timeframe: participants were followed for the duration of hospital stay, an average of 6 days
| Intervention | days (Mean) |
|---|---|
| IM Midazolam | 5.7 |
| IV Lorazepam | 4.1 |
Hospital and ICU admission from the ED, and length of stay, is abstracted from the hospital admission record. ICU admission is recorded as occurring only if the ICU is the initial inpatient unit for the patient. (NCT00809146)
Timeframe: at time of disposition on day of enrollment
| Intervention | participants (Number) |
|---|---|
| IM Midazolam | 128 |
| IV Lorazepam | 161 |
Hospital and ICU admission from the ED, and length of stay, is abstracted from the hospital admission record. ICU admission is recorded as occurring only if the ICU is the initial inpatient unit for the patient. (NCT00809146)
Timeframe: at ED disposition on day of enrollment
| Intervention | participants (Number) |
|---|---|
| IM Midazolam | 258 |
| IV Lorazepam | 292 |
Endotracheal intubation performed or attempted by EMS or within 30 minutes after ED arrival is abstracted from the ED record physician and nursing records. Endotracheal intubation includes placement of a definitive tracheal airway (oro-, naso-, cricothyroidotomy, or tracheostomy) for support of respirations or protection of airway. Non-definitive and/or non-tracheal airways (oral or nasal airways, laryngeal mask airways, or esophageal obturator airways) are not included if the patient is not subsequently intubated unless specifically deemed to have been used in lieu of tracheal intubation. (NCT00809146)
Timeframe: anytime before 30 minutes after ED arrival
| Intervention | participants (Number) |
|---|---|
| IM Midazolam | 63 |
| IV Lorazepam | 64 |
Acute hypotension is defined as a systolic blood pressure of < 90 mmHg sustained for greater than 5 minutes and for which the patient was treated with a continuous IV infusion of a vasopressor. (NCT00809146)
Timeframe: participants were followed for the duration of hospital stay, an average of 6 days
| Intervention | participants (Number) |
|---|---|
| IM Midazolam | 12 |
| IV Lorazepam | 13 |
IM injection site complications are defined as any symptoms or signs of injury or reaction at the site of the study IM injection requiring treatment. This includes extensive hematoma requiring treatment (decompression, pressure dressings, or discontinuation of anticoagulant or antithrombotic medications). Treatment does not include imaging without other interventions. This definition also includes wound infection requiring antibiotic therapy, retained foreign bodies requiring exploration and removal, or other similar wound problems. (NCT00809146)
Timeframe: participants were followed for the duration of hospital stay, an average of 6 days
| Intervention | participants (Number) |
|---|---|
| IM Midazolam | 4 |
| IV Lorazepam | 2 |
IV insertion site complications are defined as any symptoms or signs of injury or reaction at the site of the study IV placed by paramedics and used for study medication. This includes thrombosis, phlebitis, or skin infection requiring specific treatment including compresses, antibiotics, or wound care. (NCT00809146)
Timeframe: participants were followed for the duration of hospital stay, an average of 6 days
| Intervention | participants (Number) |
|---|---|
| IM Midazolam | 0 |
| IV Lorazepam | 3 |
Acute seizure recurrence is defined as any further convulsive or electrographic seizures occurring in the first 12 hours of hospitalization, if they require additional antiepileptic medications, in subjects that had been determined not to be having seizures on ED arrival. (NCT00809146)
Timeframe: within 12 hours after ED arrival
| Intervention | participants (Number) |
|---|---|
| IM Midazolam | 51 |
| IV Lorazepam | 47 |
The primary outcome was termination of seizures before arrival in the emergency department (ED) without the need for the paramedics to provide rescue therapy. Subjects did not reach the primary outcome if they were having seizures on arrival in the emergency department or if they received rescue medication before arrival. Termination of seizures on arrival was determined according to the clinical judgment of the attending emergency physician and was based on examination of the subjects, their clinical course, and results of any routine diagnostic testing. (NCT00809146)
Timeframe: Duration of prehospital care, outcome is determined upon arrival at the ED on the day of enrollment (average 20 minutes).
| Intervention | participants (Number) |
|---|---|
| IM Midazolam | 329 |
| IV Lorazepam | 282 |
Length of seizure. (NCT00326612)
Timeframe: 24 hours
| Intervention | Minutes (Median) |
|---|---|
| Intranasal Midazolam | 3.0 |
| Rectal Diazepam | 4.3 |
(NCT00326612)
Timeframe: 24 hours
| Intervention | participants (Number) |
|---|---|
| Intranasal Midazolam | 21 |
| Rectal Diazepam | 17 |
(NCT00326612)
Timeframe: 24 hours
| Intervention | participants (Number) |
|---|---|
| Intranasal Midazolam | 4 |
| Rectal Diazepam | 3 |
(NCT00326612)
Timeframe: 12 hours
| Intervention | participants (Number) |
|---|---|
| Intranasal Midazolam | 1 |
| Rectal Diazepam | 1 |
(NCT00326612)
Timeframe: 24 hours
| Intervention | participants (Number) |
|---|---|
| Intranasal Midazolam | 5 |
| Rectal Diazepam | 5 |
Respiratory depression was defined as intubation at Emergency Department discharge. (NCT00326612)
Timeframe: 24 hours
| Intervention | participants (Number) |
|---|---|
| Intranasal Midazolam | 1 |
| Rectal Diazepam | 0 |
Respiratory depression was defined as requiring oxygen at discharge from the Emergency Department. (NCT00326612)
Timeframe: 24 hours
| Intervention | participants (Number) |
|---|---|
| Intranasal Midazolam | 3 |
| Rectal Diazepam | 1 |
6 reviews available for midazolam and Recrudescence
| Article | Year |
|---|---|
Treatment of status epilepticus in children.
Topics: Anticonvulsants; Child; Child, Preschool; Diazepam; Drug Administration Schedule; Drug Therapy, Comb | 2004 |
Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Benzodiazepines; Central Nervous System Disea | 1996 |
Long-term subcutaneous infusion of midazolam for refractory delirium in terminal breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Delirium; Female; Home Care Services; Humans; Hypnotics and Sedati | 1996 |
Amineptine and midazolam dependence.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Dibenzocycloheptenes; Follow-Up Studies; Huma | 1998 |
Reversal of midazolam-induced laryngospasm with flumazenil.
Topics: Anti-Anxiety Agents; Antidotes; Conscious Sedation; Electric Countershock; Flumazenil; GABA Modulato | 1998 |
Use of midazolam for refractory status epilepticus in pediatric patients.
Topics: Anti-Anxiety Agents; Child; Drug Resistance; Humans; Midazolam; Recurrence; Status Epilepticus; Trea | 1998 |
6 trials available for midazolam and Recrudescence
| Article | Year |
|---|---|
Study protocol for Ketamine as an adjunctive therapy for major depression (2): a randomised controlled trial (KARMA-Dep [2]).
Topics: Adult; Antidepressive Agents; Depression; Depressive Disorder, Major; Humans; Ketamine; Midazolam; Q | 2023 |
Ketamine Versus Midazolam for Depression Relapse Prevention Following Successful Electroconvulsive Therapy: A Randomized Controlled Pilot Trial.
Topics: Aged; Aged, 80 and over; Anesthetics, Dissociative; Anesthetics, Intravenous; Depressive Disorder, M | 2019 |
Intramuscular versus intravenous therapy for prehospital status epilepticus.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Double-Blind Method; Emergency Medical | 2012 |
Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department.
Topics: Adolescent; Adult; Aged; Apnea; Arrhythmias, Cardiac; Cardiovascular Physiological Phenomena; Dose-R | 2006 |
Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department.
Topics: Adolescent; Adult; Aged; Apnea; Arrhythmias, Cardiac; Cardiovascular Physiological Phenomena; Dose-R | 2006 |
Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department.
Topics: Adolescent; Adult; Aged; Apnea; Arrhythmias, Cardiac; Cardiovascular Physiological Phenomena; Dose-R | 2006 |
Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department.
Topics: Adolescent; Adult; Aged; Apnea; Arrhythmias, Cardiac; Cardiovascular Physiological Phenomena; Dose-R | 2006 |
A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children.
Topics: Anti-Anxiety Agents; Anticonvulsants; Child; Child, Preschool; Diazepam; Female; Humans; Infant; Inf | 1997 |
Reemergence of stroke deficits with midazolam challenge.
Topics: Adult; Aged; Aphasia; Female; GABA Modulators; Humans; Hypnotics and Sedatives; Male; Midazolam; Mid | 2002 |
21 other studies available for midazolam and Recrudescence
| Article | Year |
|---|---|
Anesthetic Management in Tracheal Dilatation for Severe Tracheal Stenosis.
Topics: Aged; Anesthesia; Dexmedetomidine; Dilatation; Female; Humans; Hypoxia; Intubation, Intratracheal; L | 2018 |
Recurrent Seizures in 2 Patients with Magnesium Sulfate-Treated Eclampsia at a Secondary Hospital.
Topics: Anticonvulsants; Cesarean Section; Drug Therapy, Combination; Eclampsia; Female; Humans; Magnesium S | 2018 |
Safety and efficacy of a cardiologist-only approach to deep sedation for electrical cardioversion.
Topics: Aged; Anesthetics, Combined; Anesthetics, Intravenous; Atrial Fibrillation; Atrial Flutter; Cardiolo | 2019 |
Treatment options in pediatric super-refractory status epilepticus.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Diet, Ketogenic; Drug Resistant Epilepsy; Ence | 2019 |
Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic-clonic seizures.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Child; Electroencephalography; Female; GABA Mod | 2015 |
Ketamine successfully terminates malignant status epilepticus.
Topics: Anesthesia, General; Anesthetics, Dissociative; Anticonvulsants; Coma; DNA Polymerase gamma; DNA-Dir | 2008 |
Midazolam as an effective drug for severe phantom limb pain in a patient after undergoing spinal anesthesia for two consecutive surgeries in the contralateral lower limb.
Topics: Aged; Amputation, Surgical; Anesthesia, Spinal; Humans; Male; Midazolam; Phantom Limb; Recurrence | 2009 |
Ileoscopy via stoma after diverting ileostomy: a safe and effective tool to evaluate for Crohn's recurrence of neoterminal ileum.
Topics: Abdominal Pain; Adolescent; Adult; Anesthetics, Intravenous; Crohn Disease; Endoscopy, Gastrointesti | 2011 |
[A common emergency in childhood. Febrile convulsions -- what to do?].
Topics: Acetaminophen; Administration, Rectal; Age Factors; Analgesics, Non-Narcotic; Anticonvulsants; Clona | 2003 |
Atrial fibrillation storms.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Circadian Rhythm; Defibrillators, Implantab | 2003 |
[Buccal midazolam for treatment of status epilepticus or repetitive seizures].
Topics: Administration, Buccal; Adult; Child, Preschool; Electroencephalography; Humans; Male; Midazolam; Re | 2004 |
Use of intravenous midazolam and clonidine in cyclical vomiting syndrome: a case report.
Topics: Adrenergic alpha-Agonists; Child; Clonidine; Drug Therapy, Combination; Humans; Hypnotics and Sedati | 2005 |
Anesthetic management of a patient with a history of Batista procedure for dilated cardiomyopathy undergoing gastric surgery.
Topics: Anesthesia, Epidural; Anesthesia, General; Anesthetics, Intravenous; Anesthetics, Local; Bupivacaine | 2006 |
Recurrent hypotension immediately after seizures in nortriptyline overdose.
Topics: Biological Availability; Blood Pressure; Drug Overdose; Female; Heart; Humans; Hypotension; Midazola | 1994 |
Epileptic fits under intravenous midazolam sedation.
Topics: Adult; Anesthesia, Dental; Anesthetics, Intravenous; Anticonvulsants; Conscious Sedation; Epilepsy, | 1996 |
Conscious sedation: a new approach for peritonsillar abscess drainage in the pediatric population.
Topics: Adolescent; Anesthetics, Dissociative; Cellulitis; Chi-Square Distribution; Child; Child, Preschool; | 1999 |
Open lateral sphincterotomy is still the best treatment for chronic anal fissure.
Topics: Ambulatory Surgical Procedures; Anal Canal; Anesthetics, Local; Bupivacaine; Chronic Disease; Fissur | 2000 |
Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus.
Topics: Adult; Aged; Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug T | 2001 |
Feasibility of local infiltration anaesthesia for recurrent groin hernia repair.
Topics: Aged; Ambulatory Surgical Procedures; Anesthesia, Local; Anesthetics, Local; Bupivacaine; Feasibilit | 2001 |
When is a stroke actually "stable"?
Topics: Anti-Anxiety Agents; Cell Count; Cerebrovascular Circulation; Humans; Midazolam; Neurons; Receptors, | 2002 |
Heart block during abdominal surgery in a child.
Topics: Anesthesia, Inhalation; Child, Preschool; Electrocardiography; Halothane; Heart Block; Humans; Intra | 1992 |